Outcomes and Insights Products for Medical-Technology & Pharmaceutical Companies

With a shift toward comparative effectiveness and value-based purchasing initiatives, medical-technology companies are now competing in a healthcare ecosystem where outcomes and costs are primary factors in purchasing decisions. The ability to analyze, define and report clinical and economic outcomes is now a fundamental business requirement. Thus, a new form of analytics-based competition is emerging, requiring volumes of reliable and relevant benchmarking data.

Access to trusted outcomes information, however, is a substantial challenge. Even when available, accurate, comparative analysis of outcomes still requires adjusting for risk factors such as differences in patient populations, comorbidities, and complexity of procedures. These complicating factors require rigorous and consistent analytic approaches.

To win in this new environment, medical product companies need to provide objective, third-party designed, and validated cost and cost-effectiveness data to give their customers the necessary information to make effective purchasing decisions. PotentiaMetrics works as a trusted third party to cross traditional boundaries and develop multi-institutional real-world data registries, enabling the company to develop unique analytic solutions and provide third-party administrative solutions.

We help medical-technology companies:

Capture, Integrate Data to Enhance the Evidence

  • Access clinically rich and deep real-world outcomes data from a multi-institutional research base
  • Proprietary access to Individual-level, real-world evidence (RWE) 
  • Unique longitudinal patient-reported outcomes tools (PRO) data capture, functioning, quality of Life
  • Agreements to gather and incorporate continuous data from multiple providers 
  • Large enough samples to uncover insights into treatment and individual outcomes 

Employ Data Science to Uncover Insights

  • Individualized insights, derived from externally-validated, proprietary economic platforms 
  • Comparative effectiveness research (CER) outcomes and costs by procedure, provider
  • Risk-adjusted outcomes and costs by procedure, provider, performance transparency
  • Member population analysis, market identification
  • Identify cost for care across the continuum and its drivers  
  • Define treatment pathways
  • Cost-effectiveness, Purchase Decision Analysis, Value-Based Pricing

Define Outcomes Measures, Incentive Design, and Reporting 

  • Next generation outcomes metrics, beyond adherence
  • Health risk stratification
  • Risk-adjusted outcomes information for Comparative Effectiveness & QA/QI Quality Improvement (QI)
  • Support value-based care, at-risk contract metrics determination
  • Inform outcomes-based contracts and risk-sharing agreements
  • Outcomes-Based Compensation, Incentives Tied to Individual Outcomes Not Limited to Compliance/Adherence
  • Longitudinal outcomes tracking 
  • Precision performance metrics, survival, clinical response, events of interest, resource utilization
  • Nuanced, risk-stratified outcomes reporting
  • Outcomes reported by an independent party with requisite clinical expertise and genuine objectivity
  • Outcomes-based reporting, adjudication, compensation
  • R&D Productivity, Clinical trials optimization

Cultivate Learning Systems 

  • Uncover personalized insights, Identification of various subpopulations with different needs
  • Predict high-risk patients and avoid high-cost events
  • Support informed, shared-decision making, personalized treatment, improved adherence, outcomes
  • Tools and platforms that enable collaboration across providers, patients, and payers
  • Reduce unnecessary procedures, complications and related claims
  • Improved management of end of life care
  • Increase patient and provider satisfaction
  • Benchmarking, risk-adjusted clinical & economic outcomes, volumes, and other key metrics
  • Support for patient safety, quality improvement efforts, and needs of clinicians
  • Improve target price under bundled payments

Support of Healthcare Reform

  • Healthcare reform, innovation including outcomes and price transparency 
  • Meet Value-Based Care (VBC) requirements
  • Merit-based Incentive Payment System (MIPS), Measure Development Plan (MDP), Advanced Alternative Payment Models (APMs)
  • Bundled payment management
  • Coordination of information across boundaries to share care, accountability & risk